| # | Side effect | Count |
|---|---|---|
| 0 | NO ADVERSE EVENT | 231 |
| 1 | DEVICE ISSUE | 167 |
| 2 | SYRINGE ISSUE | 155 |
| 3 | DRUG INEFFECTIVE | 137 |
| 4 | MATERNAL EXPOSURE DURING PREGNANCY | 114 |
| 5 | FOETAL EXPOSURE DURING PREGNANCY | 108 |
| 6 | ARTHRALGIA | 82 |
| 7 | EXPOSURE DURING PREGNANCY | 79 |
| 8 | TREATMENT FAILURE | 79 |
| 9 | PAIN IN EXTREMITY | 69 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | RHESUS ANTIBODIES POSITIVE | 59 | 0.5315 |
| 1 | PIK3CA RELATED OVERGROWTH SPECTRUM | 4 | 0.2500 |
| 2 | RHESUS ANTIBODIES | 4 | 0.1739 |
| 3 | FOETAL-MATERNAL HAEMORRHAGE | 8 | 0.1667 |
| 4 | ISOIMMUNE HAEMOLYTIC DISEASE | 5 | 0.1316 |
| 5 | COOMBS POSITIVE HAEMOLYTIC ANAEMIA | 39 | 0.0850 |
| 6 | CONTAMINATED PRODUCT ADMINISTERED | 5 | 0.0820 |
| 7 | MISLEADING LABORATORY TEST RESULT | 6 | 0.0723 |
| 8 | COOMBS INDIRECT TEST POSITIVE | 4 | 0.0541 |
| 9 | RHESUS INCOMPATIBILITY | 6 | 0.0496 |